Literature DB >> 9878883

Nitric oxide mediates glutamate-induced mitochondrial depolarization in rat cortical neurons.

A Almeida1, J P Bolaños, J M Medina.   

Abstract

Mitochondria have been considered to be a target for glutamate neurotoxicity. The aim of the present work was to investigate the mechanisms leading to glutamate-mediated mitochondrial deenergization, as measured by mitochondrial membrane potential and cell respiration in cultured neurons. Glutamate exposure to cells induced pronounced mitochondrial depolarization associated with an impairment in neuronal respiration, leading to neuronal ATP depletion. These effects were prevented by both the nitric oxide (. NO) synthase inhibitor Nomega-nitro-l-arginine methyl ester and by the N-methyl-d-aspartate glutamate-subtype receptor inhibitor d-(-)-2-amino-5-phosphopentanoate. Our results suggest that glutamate causes ATP depletion by collapsing mitochondrial membrane potential through a.NO-mediated mechanism. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9878883     DOI: 10.1016/s0006-8993(98)01240-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Low-level laser therapy (810 nm) protects primary cortical neurons against excitotoxicity in vitro.

Authors:  Ying-Ying Huang; Kazuya Nagata; Clark E Tedford; Michael R Hamblin
Journal:  J Biophotonics       Date:  2013-10-15       Impact factor: 3.207

2.  Mfn2 downregulation in excitotoxicity causes mitochondrial dysfunction and delayed neuronal death.

Authors:  Alejandro Martorell-Riera; Marc Segarra-Mondejar; Juan P Muñoz; Vanessa Ginet; Jordi Olloquequi; Jeús Pérez-Clausell; Manuel Palacín; Manuel Reina; Julien Puyal; Antonio Zorzano; Francesc X Soriano
Journal:  EMBO J       Date:  2014-08-21       Impact factor: 11.598

3.  Excitotoxic mitochondrial depolarisation requires both calcium and nitric oxide in rat hippocampal neurons.

Authors:  J Keelan; O Vergun; M R Duchen
Journal:  J Physiol       Date:  1999-11-01       Impact factor: 5.182

4.  S-nitrosylation of mixed lineage kinase 3 contributes to its activation after cerebral ischemia.

Authors:  Shu-Qun Hu; Jun-Song Ye; Yan-Yan Zong; Chang-Cheng Sun; Dong-Hai Liu; Yong-Ping Wu; Tao Song; Guang-Yi Zhang
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

5.  Mitochondrial membrane potential and glutamate excitotoxicity in cultured cerebellar granule cells.

Authors:  M W Ward; A C Rego; B G Frenguelli; D G Nicholls
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

6.  Persistent mitochondrial damage by nitric oxide and its derivatives: neuropathological implications.

Authors:  Juan P Bolaños; Simon J R Heales
Journal:  Front Neuroenergetics       Date:  2010-02-03

7.  Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease.

Authors:  Gjumrakch Aliev; Hector H Palacios; Amanda E Lipsitt; Kathryn Fischbach; Bruce T Lamb; Mark E Obrenovich; Ludis Morales; Eldar Gasimov; Valentin Bragin
Journal:  Neurotox Res       Date:  2009-05-30       Impact factor: 3.911

8.  Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats.

Authors:  Aparajita Ghosh; Sibani Sarkar; Ardhendu K Mandal; Nirmalendu Das
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

9.  Mitochondrial calcium uniporter Mcu controls excitotoxicity and is transcriptionally repressed by neuroprotective nuclear calcium signals.

Authors:  Jing Qiu; Yan-Wei Tan; Anna M Hagenston; Marc-Andre Martel; Niclas Kneisel; Paul A Skehel; David J A Wyllie; Hilmar Bading; Giles E Hardingham
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 10.  Oxidative Stress Induced Mitochondrial Failure and Vascular Hypoperfusion as a Key Initiator for the Development of Alzheimer Disease.

Authors:  Gjumrakch Aliev; Hector H Palacios; Eldar Gasimov; Mark E Obrenovich; Ludis Morales; Jerzy Leszek; Valentin Bragin; Arturo Solís Herrera; Dmitry Gokhman
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.